Russian Call Girls Lucknow âš7.5k Pick Up & Drop With Cash Payment 8923113531 ...
Â
2019 parm 2223 mod 8 circulatory assist devices
1. Stop Dragginâ My Heart
AroundâŚ.
Life Sustaining Interventions in EMS and Critical Care: An Overview
2. Objectives
Compare and Contrast ECMO, VAD, IABP,
and TAH
Properly assess a patient with a VADs,
IABPs, or TAHs.
Discuss treatment strategies for patients
with VADs, IABPs, or TAHs.
Discuss prehospital and intra-facility
implications of patients with ECMO, VADs,
IABPs, or TAHs.
3. Definitions
⢠ECMO: Extracorporeal Membrane Oxygenation
⢠IABP: Intra-aortic balloon pump
⢠VAD: Ventricular Assist Device
⢠L-VAD: Left Ventricular Assist Device
⢠TAH: Total Artificial Heart
⢠Bridge Therapy: Temporary therapy to âbridgeâ to definitive therapy
⢠Destination Therapy: Anticipated terminal therapy. While not
âdefinitiveâ, probably the best available for the patient circumstances.
6. Ventricular Assist
Devices
⢠A VAD is a Mechanical Circulatory Support
(MCS) device designed to restore blood
flow and improve survival, functional
status, and quality of life for those suffering
from advanced heart failure
⢠The device is implanted in parallel with the
heart, taking over a majority of its
circulatory function
⢠Multiple devices and brands in use
⢠Refer to the ICCAC Field Guide
⢠No age limit
7. There are currently over 60 LVAD patients in Idaho
Nate Southerland, eastidahonews.com in 2016
8. Ventricular Assist
Devices
⢠The device takes blood from a
lower chamber of the heart
and helps pump it to the body
and vital organs, just as a
healthy heart would.
⢠It âassistsâ the left
ventricular function of the
heart.
9. Types of VADs
⢠L-Vad â Left Ventricular Assist
Devices
⢠R-VAD â Right Ventricular Assist
Devices
⢠BiVAD- Bi-Ventriculat Assist
Devices.
⢠Total Artificial Hearts (discussed
later)
10. Types of VADs
⢠A BiVad is not a
separate class of VAD,
but the combination
of Left and Right VADs
in the same patient.
11. Ventricular Assist
Device
⢠Implanted in heart failure patients
⢠Augments the function of the
ventricles in circulating blood
⢠Sometimes implanted as a
temporary treatment (âbridge
therapyâ , and sometimes used as a
permanent solution âdestination
therapyâ to very low cardiac output
12. Ventricular Assist Device (VAD)
⢠There are 3 common indications for implanting an LVAD:
⢠Bridge to Transplant
⢠The patient must meet criteria to be listed for a heart transplant
⢠The VAD is taken out at time of transplant
⢠Destination Therapy
⢠The patient does not qualify for a heart transplant but meets criteria for
Destination Therapy
⢠The patient lives the rest of their life with an VAD
⢠Bridge to Recovery
⢠VAD for a few days or weeks, provides temporary support
⢠Ex. Patient with post partum cardiomyopathy
13. Ventricular
Assist
Devices
⢠The device is âpoweredâ externally, with the âdrive lineâ entering the
body to run the âpumpâ
⢠Think of the driveline as the âPTOâ of a tractor.
⢠The actual âpowerâ is external in the âcontrollerâ.
14. VAD Special Considerations
⢠VAD patients are unique and require specialized care
⢠Routine assessments such as blood pressure, pulses, and pulse-
oximetry may not be unattainable
⢠Chest compressions are usually not indicated
⢠The patients carry external equipment: a controller and power
sources that operate the implanted pump though a single driveline
15. VAD Patient
Assessment
⢠Attempt to auscultate over the apex of the
heart for a âwhirlingâ or âsmooth,
hummingâ sound indicating that the VAD
is working
⢠A cable exits the abdominal wall that
connects the device to power and the
control unit
⢠SOME VAD patients also have an
implanted cardiac defibrillator and/or a
pacemaker
16. Example of L-VAD system: HeartWare
System
Implanted Pump
Driveline
Battery Battery
Controller
17. Example of L-VAD system: HeartMate II
System
Implanted Pump
Battery
Battery
Controller Driveline
18. External VAD Components
Patients have options for carrying their
external equipment to best suit their
comfort and lifestyle
Ensure that the equipment is
protected
at all times with no stress on
the driveline
Patients will have an additional
supply bag for their extra batteries and
backup Controller close at hand. This bag
should always accompany the patient on
transport
20. Power Management
⢠Patients are responsible for managing their
power
⢠They have 6-8 batteries in rotation and a
home charger
⢠Batteries generally last 8 â 14 hours per pair
⢠Exchanged one at a time, so one
⢠power source is always connected
⢠to the Controller
⢠Patients only need to be on A/C power when
sleeping
21. Critical VAD Connections
Never disconnect both power sources! Never disconnect driveline!
HeartWare HVAD HeartMate II
Power
Driveline
Power
Power
PowerDriveline
22. The Controller
For HeartMate 2 and 3
press MENU button
to access parameters
ALARM SILENCE
Alarms have symbol
and message on screen
Yellow (beeps)
Pump is ON
Red (steady tone)
Pump may be OFF
23. Assessments
⢠MOST L-VADS are a continuous flow device. This means:
⢠Whirling sound in chest.
⢠No Pulse: A palpable pulse is variable and clinically insignificant in VAD patients
⢠Pulse Oximetry: Pleth will be unreliable. SPO2 may still be useful though.
⢠Look for physical s/s of â oxygenation
⢠No systolic or diastolic blood pressure
⢠NIBP may be able to get a MAP
⢠Doppler B/P = MAP
⢠Rely on other prefusion signs
⢠EKG is typically unaffected (may be AF, , Stable VT, or even VF!!! or other
underlying condition)
⢠Rely on total assessment.
⢠Assess for bleeding issues. Patients are at high risk for bleeding complications
due to blood thinner use
⢠Trauma
⢠Falls
⢠GI bleed
24. Assessments: LOOK AT THE CONTROLLER
What is the flow rate???
What are the RPMs?
Alarms have symbol
and message on screen
Yellow (beeps)
Pump is ON
Red (steady tone)
Pump may be OFF
26. Caution with clothing removal
⢠Use caution when cutting and removing
clothes, to avoid damaging the device
⢠VAD patients should always have a sterile
dressing covering the driveline exit site in the
lower abdomen.
⢠The dressing should not get wet.
27. VAD complications: infection
⢠Many hospital admissions in VAD patients
are secondary to infection, not cardiac
problems.
⢠Assess for signs of infection (especially at
the insertion point) or sepsis
28. Assessing Pump Flow
⢠Flow (L/min)
⢠Average adult Cardiac Output at rest is ~ 5
L/min
⢠Body size / blood volume effects pump
flow potential
⢠The Flow parameter is an estimate
⢠Flow will mainly fluctuate with changes in
activity, body position, and blood volume
⢠Hyper / hypovolemia
⢠Other physiologic conditions can also effect
flow:
⢠Right Heart Function
⢠Rhythm disturbances
⢠Hypo / hypertension
⢠Valvular function
⢠Pulmonary hypertension
⢠Thrombosis
29. Assessing for signs of Hypovolemia
Normal Flow Range 4 â 6 L/min
Asymptomatic
Sub-optimal Flow 2.5 â 3.5 L/min
Asymptomatic â Symptomatic
May be dizzy, lightheaded, fatigued, change in LOC
Low Flow < 2.5 L/min
Asymptomatic â Symptomatic
May be dizzy, lightheaded, fatigued, change in LOC
30. Treatment
⢠***CALL THE VAD HOTLINE ***
⢠Verify the pump is âonâ
⢠Treat as important as a âpulse checkâ.
⢠Involve Caregivers. They have had extended training in the patientâs
particular VAD.
⢠V.O.M.I.T. as indicated
⢠Hypovolemia is a common complication
⢠Fluid Resuscitation is a common intervention.
⢠Vasopressors for patients refractory to fluid challenges.
31. LVAD Patient Management
PRELOAD
Volume
Blood Pressure
CVP / PVR
Right Heart Function
Valvular Function
Rhythm
AFTERLOAD
SVR
MAP 65-85
ANTICOAGULATION
Coumadin
ASA
INR 2-3
PUMP SPEED
Set RPM to
BLOOD IN = BLOOD OUT
32. Treatment â ACLS?
⢠***CALL THE VAD HOTLINE ***
⢠Airway management and respiratory support considerations unchanged
⢠OK to defibrillate or SCV per ACLS, but consult VAD Hotline first if the patient is
stable
⢠Avoid placing the pads directly over the device (consider anterior-posterior pad placement)
⢠Do Not Administer vasodilatory meds without consulting the VAD hotline.
⢠i.e. Nitroglycerine
⢠Persistent arrhythmias are treated after contacting the VAD coordinator
⢠Antiarrhythmics doses unchanged by LVAD, but may be changed by other underlying
conditions.
⢠CPR is usually last resort.
⢠LISTEN for âwhirling soundâ first. If present, no CPR unless ordered by VAD-Control Center
33. Transportation and Destination Decisions
⢠***CALL THE VAD HOTLINE ***
⢠Always transport âgo-Bagâ with the patient.
⢠If possible, take an experienced care giver too.
⢠These patients have multiple co-morbidities and high risk clinical concerns
⢠Heart Failure
⢠Stroke
⢠LVAD related issues
⢠High risk of infection
⢠Coagulopathic issues
⢠These patients should be transported to either the VAD center, or in Idaho,
the highest level of care available (major medical centers). Consult VAD
hotline.
Q: What does that mean in your local area?
35. Total Artificial Heart
⢠Surgically implanted, externally powered
⢠Technically a âBiVADâ.
⢠The lower ventricles are surgically
removed
⢠Takes up less space in the chest than a
VAD.
36. Bridge Therapy
⢠Bridge Therapy offers a
62% chance of 2 year
survival
⢠Medical Therapy Less
than 26% survival for 1
year
⢠10% 2 year survival
https://healthblog.uofmhealth.org/heart-health/living-for-
years-without-a-heart-now-possible
37.
38. TAH
⢠The device is
implanted in place
of the lower
portions of the
heart, taking over a
majority of its
circulatory function
39.
40. VAD versus TAH
Ventricular Assist Device
⢠Usually Pulseless
⢠Whirling assessed by auscultation
⢠EKG has underlying rhythm
⢠No NTG (*preload dependent)
⢠Cardioversion/Defibrillation OK
⢠CPR OK
⢠Mean Arterial Pressure only.
⢠MAP 70-85 mm Hg
⢠Often have an ICD/Pacemaker
Total Artificial Heart
⢠Pulsatile
⢠Externally perceptible
⢠EKG asytolic or minimally active
⢠NTG for SBP > 140 mm Hg
⢠No cardioversion/defibrillation
⢠No CPR
⢠Normal BP
⢠No ICD/Pacemaker
41. Assessments
⢠MOST TAHs are a pulsatile flow device. This means:
⢠You should hear two sounds if properly.
⢠Pulse Oximetry: Pleth will be present. SPO2 useful.
⢠Look for physical s/s of â oxygenation
⢠Blood Pressure: Since there is a pulsatile waveform , there is a blood
pressure.
⢠The majority of the heart has been removed. Therefore the EKG is
typically asystole or minimally active.
⢠Assess for bleeding issues. Patients are at high risk for bleeding
complications due to blood thinner use
⢠Trauma
⢠Falls
⢠GI bleed
42. Treatment
⢠***CALL THE TAH HOTLINE ***
⢠Check for a pulse.
⢠Verify the pump is âonâ
⢠Treat as important as a âpulse checkâ.
⢠Involve Caregivers. They have had extended training in the patientâs
particular VAD.
⢠V.O.M.I.T. as indicated
⢠Hypovolemia is a common complication
⢠Fluid Resuscitation is a common intervention.
⢠Vasopressors for patients refractory to fluid challenges.
43. Treatment â ACLS?
⢠***CALL THE TAH HOTLINE ***
⢠Airway management and respiratory support considerations
unchanged
⢠No Defibrillation (nothing left to defibrillate)
⢠Do Not Administer vasodilatory meds without consulting the TAH
hotline.
⢠i.e. Nitroglycerine
⢠No antiarrhythmics required
⢠No CPR (not enough heart left to compress)
44. Transportation and Destination Decisions
⢠***CALL THE VAD HOTLINE ***
⢠Always transport âgo-Bagâ with the patient.
⢠If possible, take an experienced care giver too.
⢠These patients have multiple co-morbidities and high risk clinical concerns
⢠Heart Failure
⢠Stroke
⢠LVAD related issues
⢠High risk of infection
⢠Coagulopathic issues
⢠These patients should be transported to either the VAD center, or in Idaho,
the highest level of care available (major medical centers). Consult TAH
hotline.
Q: What does that mean in your local area?
46. Intra-Aortic
Balloon Pumps
⢠An intra-aortic balloon pump
(IABP) is a type of therapeutic
device. It helps heart function. It is
often used as a bridge
intervention to more definitive
therapy.
⢠The IABP consists of a thin, flexible
tube called a catheter. Attached to
the tip of the catheter is a long
balloon. This is inserted into the
aorta.
47. Indications for IABP
Indications
⢠Cardiogenic Shock
⢠Pre-shock syndrome
⢠Threatening extension of MI
⢠Unstable angina
⢠Intractable ventricular dysrhythmias
⢠Septic Shock
⢠Cardiac Contusion
⢠Prophylactic support
⢠Bridging device to other mechanical
assist
⢠Support during transport
Contraindications
⢠Absolute
⢠Aortic Valve insufficiency
⢠Dissecting aortic aneurysm
⢠Relative
⢠End-stage cardiomyopathies
⢠Severe atherosclerosis
⢠End stage terminal disease
⢠Abdominal aortic aneurysm
⢠Blood dyscrasias
⢠Thrombocytopenia
48. The Cardiac Cycle (Remember this?)
⢠The ventricles propel blood throughout
the pulmonary and systemic circulation
as a result of ventricular contraction.
⢠Fluid (blood) always flows from high
pressure to low.
⢠The cardiac cycle is divided into systole
(ventricular contraction) and diastole
(ventricular relaxation and filling)
http://www.nhf.org.nz/images/how_your_heart_works.gif
49. Preload vs. Afterload (Remember this too?)
⢠Preload refers to the amount of stretch on the ventricular
myocardium prior to contraction. Starlingâs law described how
an increase of volume in the ventricle at the end of diastole
resulted in an increase in the volume of blood pumped out.
⢠Preload is often referred to as âfilling pressureâ.
⢠Afterload is the resistance to ventricular ejection which takes
several forms:
⢠The mass of blood that must be moved, measured by the hematocrit
⢠The higher the mass, the more inertia that must be generated.
⢠Aortic end diastolic pressure (AEDP).
⢠If the AEDP is 80 mm/hg, then the left ventricle must generate 81 mm/hg
in order to open the aortic valve and generate blood flow.
⢠Arteriole resistance
50. IABP- How it works
⢠The IABP is attached to a controller. The controller has a mechanism
for inflating and deflating the balloon in synchronization with the
heart.
⢠Inflation during diastole
⢠Deflation during systole
⢠Catheter
⢠30-cm polyurethane balloon on distal end
⢠Balloons sized according to height
⢠Placed in aorta distal to left of subclavian artery . Position is critical
⢠Inserted in femoral artery
⢠During operation, rapidly inflated and deflated with 35â40 ml of helium
⢠Inflated to about 85-90% of diameter of aorta to avoid damage to vessels.
51.
52. Inflation is timed off of multiple paramters
https://www.teleflex.com/usa/product-
areas/interventional/cardiac-assist/ac3-optimus-iabp/
59. Extracorporeal
Membrane Oxygenation
(ECMO)
⢠ECMO is a form of cardio-pulmonary bypass.
⢠It is a life support system that temporarily replaces
the function of the heart and the lungs.
⢠This is a life-saving measure often used in the ER or
OR, ICU, or in other specialized settings to assist
patients who have no blood pressure and failing
after a large heart attack.
60. Extracorporeal Membrane
Oxygenation
(ECMO)
⢠Started in the ORs and CVICUs in the 70âs.
⢠Now done in larger ER/EDs, ICUs, NICUs, and even in the pre-hospital
setting.
⢠Done in all age ranges
⢠ECMO is just one form of Cardio-pulmonary bypass
⢠Significant in that ECMO can be done via larger central
vasculature, but does not have to be placed in the aorta or
vena cava.
61. Types of ECMO
Veno-Arterial
⢠Requires cannulation of an artery
and a venin
⢠Used in cases where cardiac
support is needed.
⢠Post-ROSC
⢠Severe Hypothermia (can re-warm
too)
⢠Toxic exposures
⢠Even during cardiac arrest
Veno-Venous
⢠Requires cannulation of two veins
⢠Predominantly for cases of
Respiratory failure where
cardiovascular support is not
crucial
⢠ARDS, Drowning, etc
62.
63.
64. ECMO in the near
future
⢠Transportation of refractory cardiac arrest patients to ECMO
Centers
⢠Out of hospital physicians placing ECMO
⢠ECMO in the ED for sepsis, OD, cardiogenic shock, and who
knows what elseâŚ
⢠Partial support (partial ECMO) V-V systems similar to dialysis
machines with bicaval catheters.
The basic parts of a VAD include: a small
tube that carries blood out of your heart into a
pump; another tube that carries blood from the
pump to your blood vessels, which deliver the
blood to your body; and a power source.
The two basic types of VADs are a left ventricular assist device (LVAD) and a right ventricular assist device (RVAD). If both types are used at the same time, they may be called a biventricular assist device (BIVAD). However, a BIVAD isn't a separate type of VAD.
The LVAD is the most common type of VAD. It helps the left ventricle pump blood to the aorta. The aorta is the main artery that carries oxygen-rich blood from your heart to your body.
RVADs usually are used only for short-term support of the right ventricle after LVAD surgery or other heart surgery. An RVAD helps the right ventricle pump blood to the pulmonary (PULL-mun-ary) artery. This is the artery that carries blood to the lungs to pick up oxygen.
Both an LVAD and RVAD (sometimes called a BIVAD) are used if both ventricles don't work well enough to meet the needs of the body. Another treatment option for this condition is a total artificial heart.
What is the power source?
The power source is either batteries or AC power. The power source is connected to a control
unit that monitors the VADâs functions. The batteries are carried in a case usually located in a
holster in a vest wrapped around the patients shoulders.
What does the control unit or controller do?
The control unit gives warnings, or alarms, if the power is low or if it senses that the device
isnât working right. It is a computer.
Auscultate below the apex the device sits below the diaphragm.
Because they have a blood pump, VAD patients may be stable in V-Tach or V-Fib
VAD flows may be affected
Persistent arrhythmias are treated after contacting the VAD coordinator
Many VAD patients have an ICD / Pacemaker
If patientâs ICD delivers a shock, notify VAD Coordinator
Okay to defibrillate & cardiovert VAD patients per ACLS protocol
Okay to administer anti-arrhythmic medications per ACLS protocol
All VAD patients are on anticoagulation medications
They are at high risk for embolic or hemorrhagic stroke.
Level of consciousness may deteriorate rapidly
Because patients are already anti-coagulated, they do not follow routine stroke protocol
By auscultating over the apex, providers will be listening over the device itself.
67 yo patient went into cardiac arrest after he accidentally cut his LVAD wires. ED physician reconnected with hemostats and restored flow.
While this chart depicts pump flow, it is important for EMS to recognize signs and symptoms of hypovolemia
https://well.blogs.nytimes.com/2011/02/14/a-plastic-heart-that-beat-for-three-days/?_r=0âNearly 42 years ago, the worldâs first artificial heart was implanted in a history-making operation at St. Lukeâs Hospital in Houston.
The patient, 47-year-old Haskell Karp, was dying of heart failure and awaiting a heart transplant. The artificial device, implanted April 4, 1969, kept him alive for three days until a human heart was available for transplant. Sadly, he lived less than two days after the human heart was implanted. The procedure also led to one of the longest-running feuds in medical history.
â https://www.nytimes.com/2007/11/27/health/27docs.html?scp=1&sq=denton%20cooley&st=cse
Total Artificial Heart is the only device that provides immediate, safe blood flow of up to 9.5 L/min through both ventricles to help vital organs recover faster. Once stable, Total Artificial Heart patients in the hospital are listed UNOS Status 1A and moved to the top of the transplant list. Compared to all heart devices, the SynCardia TAH has the highest rate of successful bridge-to-transplant.
https://healthblog.uofmhealth.org/heart-health/living-for-years-without-a-heart-now-possible Stan Larkin, pictured above, a 25-year-old with a rare form of cardiomyopathy who lived for 555 days â outside of the hospital â using a Total Artificial Heart before receiving a heart transplant at UMHS in May. âHeâs absolutely thriving now.â
The two basic types of VADs are a left ventricular assist device (LVAD) and a right ventricular assist device (RVAD). If both types are used at the same time, they may be called a biventricular assist device (BIVAD). However, a BIVAD isn't a separate type of VAD.
The LVAD is the most common type of VAD. It helps the left ventricle pump blood to the aorta. The aorta is the main artery that carries oxygen-rich blood from your heart to your body.
RVADs usually are used only for short-term support of the right ventricle after LVAD surgery or other heart surgery. An RVAD helps the right ventricle pump blood to the pulmonary (PULL-mun-ary) artery. This is the artery that carries blood to the lungs to pick up oxygen.
Both an LVAD and RVAD (sometimes called a BIVAD) are used if both ventricles don't work well enough to meet the needs of the body. Another treatment option for this condition is a total artificial heart.
IABP pump
Rate adjustable
1:1, 1:2, 1:8
Inflation volume adjustable
A flexibile catheter is inserted into the femoral artery and passed into the descending aorta.
Correct positioning is critical in order to avoid blocking off the subclavian, carotid, or renal arteries.
When inflated, the balloon blocks 85-90% of the aorta. Complete occlusion would damage the walls of the aorta, red blood cells, and platelets.
Helium is rapidly pumped into and out of the balloon (about 40ccs). When inflated, this balloon displaces the blood that is in the aorta.
This is known as counter pulsation
Helium is used because it is a soluble gas and will not cause an embolus if the balloon ruptures
This sudden inflation moves blood superiorly and inferiorly to the balloon.
When the balloon is suddenly deflated, the pressure within the aorta drops quickly.
Inflation of the balloon occurs at the onset of diastole. At that point, maximum aortic blood volume is available for displacement because the left ventricle has just finished contracting and is beginning to relax, the aortic valve is closed, and the blood has not had an opportunity to flow systemically.
The pressure wave that is created by inflation forces blood superiorly into the coronary arteries.
This helps perfuse the heart.
Blood is also forced inferiorly increasing perfusion to distal organs (brain, kidneys, tissues, etc.)
The balloon remains inflated throughout diastole.
At the onset of systole, the balloon is rapidly deflated. The sudden loss of aortic pressure caused by the deflation reduces afterload.
The left ventricle does not have to generate as much pressure to achieve ejection since the blood has been forced from the aorta.
This lower ejection pressure reduces the amount of work the heart has to do resulting in lower myocardial oxygen demand.
As you can see, inflation and deflation timing is critical in order to obtain the maximum benefits from the pump.
Incorrect timing can result in poor patient outcomes.
https://www.youtube.com/watch?v=mADxD7C8jBw
Mixed results in studies. Appears to improve short term outcomes. 30 day mortality unchanged. During a cardiac arrest, the IABP can provide very effective perfusion in conjunction with external compressions. Diastolic blood pressure and coronary perfusion pressure were significantly higher with the IABP. Circulation times were shorter and end-tidal CO2 was higher with theIABP. It was concluded that the IABP improves hemodynamic parameters during experimental cardiac arrest.
Since there is no ECG signal and no arterial pressure wave to trigger the pump, an internal trigger is selected.
This trigger detects the flow of blood caused by compressions and inflates the balloon providing improved circulation.
Good, consistent compressions are a must for this to work!
Use of the Autopulse/LUCAS in these situations has not been studied.
An IABP is an option in smaller hospitals without complex cardiothoracic capability or ECMO capability.
CPB is used in the OR during cardiac surgical cases as mechanical circulatory and oxygenation support for organ preservation Modern-day CPB was introduced in the 1950s, and the development of adult ECMO support for respiratory distress began in the 1970s
Over the past several years technological advances have allowed ECMO machines to become smaller, about the size of a large cardiac monitor weighing just over 25 pounds, and even portable enough to fit in most ambulances. As the size of the ECMO machine has shrunk, the role of ECMO has expanded rapidly.
There are two main types of ECMO therapy: venoarterial ECMO (V-A ECMO) and veno-venous ECMO (V-V ECMO). Simply put, V-A ECMO provides cardiac and respiratory support while V-V ECMO provides primarily respiratory support to the bodyVeno-venous ECMO is used to support respiratory conditions; the patient's heart function remains undisturbed by the procedure. Blood is reintroduced through another venous catheter into a different large vein, typically the femoral vein or internal carotid vein. The oxygenated blood then goes through the normal circulatory process. In this method the patientâs normal hemostatic actions remain intact.
Veno-arterial ECMO is used when the patientâs cardiac output is absent or insufficient to support life. Oxygenated blood is delivered directly into a large artery, typically the right carotid common artery or the iliac artery, bypassing the heart completely.
Confi guration of ECMO support
(A) Veno-venous (V-V) ECMO. Extracorporeal gas exchange occurs in venous blood, which is then returned to the
venous circulation. V-V ECMO provides no direct hemodynamic support. (B) Veno-arterial (V-A) ECMO. Venous blood
is actively pumped into the system circulation, effectively bypassing the cardiorespiratory system. V-A ECMO is partial
CPB.
The SAVE-J Trial done in Japan, as well as studies from San Diego and Australia, have demonstrated significant positive outcomes for patients with refractory cardiac arrest who received ECMO. These patients with prolonged own time would typically have resuscitative measures ceased and death certain. However, patients with a relatively short down time, 45 minutes from collapse to initiation of ECMO, can survive with quality neurological outcomes when ECMO is initiated in conjunction with therapeutic hypothermia. Cardiac arrest protocols in the future may call for patients who meet certain criteria to be placed on a mechanical CPR device for transport to the hospital for initiation of ECMO prior to ROSC.
EDECMO Crash Episode â Demetris Yannopoulos on ECPR-the Minneapolis Way
Current evidence supports ECMO as a lifesaving intervention
that can be safely used in themanagement of severely injured
trauma patientswith severe respiratory failure.
ECMO in the far futureThe ECPR response team in Paris implements ECMO on scene to restore blood flow to the body and limit ischemic consequences to the brain and coronary arteries. Photos courtesy Service d'Aide Medical d'Urgence (SAMU) de Paris